Jupiter Neurosciences, Inc.
JUNS
$1.11
-$0.13-10.48%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.53M | -1.53M | -591.00K | 313.10K | -634.10K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 189.00K | 82.90K | 5.00K | 5.00K | 5.00K |
| Total Other Non-Cash Items | 421.50K | 1.11M | 185.20K | -649.50K | 353.00K |
| Change in Net Operating Assets | -144.70K | -3.36M | 358.20K | 223.90K | 210.90K |
| Cash from Operations | -1.06M | -3.70M | -42.60K | -107.50K | -65.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | 1.50K | 28.00K | 64.00K | 45.00K |
| Total Debt Repaid | -- | -2.36M | -- | -- | -- |
| Issuance of Common Stock | -- | 100.00K | 0.00 | 50.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 9.73M | -- | -- | -- |
| Cash from Financing | -- | 7.47M | 28.00K | 114.00K | 45.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.06M | 3.77M | -14.60K | 6.50K | -20.20K |